Company / PP&E (Net)
Incyte PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$730.9M
FY2025
5-year range
$723.9M / $763.4M
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
#19 of 193
Health Care
What the data says
Among 193 Health Care companies, Incyte is in the top 10% for pp&e (net). Declined from $752M to $731M over the past 2 years.
Based on SEC 10-K filings.
$731M in FY2025 with a 5-year CAGR of +5.5%. Top quartile in the Health Care sector.
Declined from $752M to $731M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -0.4%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 193This company $730.9M Sector average $777.6M
▼
-6.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.5%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 4.3% year-over-year.
- Ranks #19 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $730.9M | -4.3% |
| FY2024 | $763.4M | +1.6% |
| FY2023 | $751.5M | +1.7% |
| FY2022 | $739.3M | +2.1% |
| FY2021 | $723.9M | +29.4% |
| FY2020 | $559.6M | +48.2% |
| FY2019 | $377.6M | +18.1% |
| FY2018 | $319.8M | +23.1% |
| FY2017 | $259.8M | +54.9% |
| FY2016 | $167.7M | +95.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026